CDK4 and melanoma: For melanomas, regulators of the cell cycle’s G1 phase transition such as D and E type cyclins, CDK4/6, CDK inhibitors including p16 and p14, and retinoblastoma protein were suggested as diagnostic tools or therapeutic targets [13, 32–34].